Topic

Pennsylvania

A collection of 524 issues

UnitedHealthcare's Coverage Criteria for Elfabrio in Pennsylvania: What Counts as "Medically Necessary"?

Answer Box: Getting Elfabrio Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Elfabrio (pegunigalsidase alfa-iwxj) with confirmed Fabry disease diagnosis via genetic testing or enzyme deficiency, plus documented organ involvement. Submit PA through OptumRx provider portal with specialist evaluation, genetic/enzyme results, and clinical evidence of kidney, heart,
6 min read

The Complete Guide to Getting Vanflyta (Quizartinib) Covered by Cigna in Pennsylvania: Prior Authorization Forms, Appeals Process, and Medical Necessity Requirements

Answer Box: Getting Vanflyta Covered by Cigna in Pennsylvania Prior authorization is required for Vanflyta (quizartinib) under Cigna Health Plans in Pennsylvania. The fastest path to approval requires: (1) FLT3-ITD mutation confirmation via FDA-approved test, (2) baseline ECG with QTc <450ms, and (3) submission through CoverMyMeds or Cigna'
6 min read

How to Get Vimizim (elosulfase alfa) Covered by Aetna (CVS Health) in Pennsylvania: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Vimizim Covered by Aetna in Pennsylvania Aetna (CVS Health) requires prior authorization for Vimizim (elosulfase alfa) in Pennsylvania. To get approved: (1) Submit confirmed MPS IVA diagnosis via GALNS enzyme deficiency test or genetic testing through your specialist, (2) Complete Aetna's Vimizim precertification form and
6 min read

How to Get Hemgenix (etranacogene dezaparvovec) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Hemgenix Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Hemgenix (etranacogene dezaparvovec) with strict eligibility criteria including age 18+, severe/moderately severe hemophilia B, 50+ factor IX exposure days, and treatment at a hemophilia center. If denied, Pennsylvania's Independent External Review Program offers
6 min read

Work With Your Doctor to Get Tavalisse (Fostamatinib) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Prior Authorization Guide

Quick Answer: Getting Tavalisse Covered in Pennsylvania To get Tavalisse (fostamatinib) covered by Blue Cross Blue Shield in Pennsylvania, you'll need prior authorization from a hematologist or oncologist documenting chronic ITP diagnosis, platelet count below 30,000/μL, and failure of first-line therapies (corticosteroids, IVIG, or TPO agonists)
6 min read